Condition: High Blood Sugar · Metabolic Syndrome · Sponsor: SunWay Biotech Co., LTD.
This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)
This description comes directly from the study's public registry record.
Sean Lin · 02-27929568 · sean.lin@sunway.cc
Always discuss trial participation with your own doctor first.
| Tri-Service General Hospital, National Defense Medical Center, Taipei city, | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05737342